393 related articles for article (PubMed ID: 18465299)
1. Topical delivery of urea encapsulated in biodegradable PLGA microparticles: O/W and W/O creams.
Haddadi A; Aboofazeli R; Erfan M; Farboud ES
J Microencapsul; 2008 Sep; 25(6):379-86. PubMed ID: 18465299
[TBL] [Abstract][Full Text] [Related]
2. Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: release kinetics and stability issues.
Crotts G; Park TG
J Microencapsul; 1998; 15(6):699-713. PubMed ID: 9818948
[TBL] [Abstract][Full Text] [Related]
3. G-CSF loaded biodegradable PLGA nanoparticles prepared by a single oil-in-water emulsion method.
Choi SH; Park TG
Int J Pharm; 2006 Mar; 311(1-2):223-8. PubMed ID: 16423477
[TBL] [Abstract][Full Text] [Related]
4. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
[TBL] [Abstract][Full Text] [Related]
5. Water-soluble betamethasone-loaded poly(lactide-co-glycolide) hollow microparticles as a sustained release dosage form.
Chaw CS; Yang YY; Lim IJ; Phan TT
J Microencapsul; 2003; 20(3):349-59. PubMed ID: 12881115
[TBL] [Abstract][Full Text] [Related]
6. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles.
Kumar PS; Ramakrishna S; Saini TR; Diwan PV
Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069
[TBL] [Abstract][Full Text] [Related]
7. Development of pH- and time-dependent oral microparticles to optimize budesonide delivery to ileum and colon.
Krishnamachari Y; Madan P; Lin S
Int J Pharm; 2007 Jun; 338(1-2):238-47. PubMed ID: 17368982
[TBL] [Abstract][Full Text] [Related]
8. Issues in long-term protein delivery using biodegradable microparticles.
Ye M; Kim S; Park K
J Control Release; 2010 Sep; 146(2):241-60. PubMed ID: 20493221
[TBL] [Abstract][Full Text] [Related]
9. Iodo-2'-deoxyuridine (IUdR) and 125IUdR loaded biodegradable microspheres for controlled delivery to the brain.
Reza MS; Whateley TL
J Microencapsul; 1998; 15(6):789-801. PubMed ID: 9818956
[TBL] [Abstract][Full Text] [Related]
10. Preparation of protein loaded poly(D,L-lactide-co-glycolide) microparticles for the antigen delivery to dendritic cells using a static micromixer.
Wischke C; Lorenzen D; Zimmermann J; Borchert HH
Eur J Pharm Biopharm; 2006 Apr; 62(3):247-53. PubMed ID: 16288857
[TBL] [Abstract][Full Text] [Related]
11. Influence of processing on the stability and release properties of biodegradable microspheres containing thioridazine hydrochloride.
O'Donnell PB; McGinity JW
Eur J Pharm Biopharm; 1998 Jan; 45(1):83-94. PubMed ID: 9689539
[TBL] [Abstract][Full Text] [Related]
12. Influence of post-emulsification drying processes on the microencapsulation of human serum albumin.
Lane ME; Brennan FS; Corrigan OI
Int J Pharm; 2006 Jan; 307(1):16-22. PubMed ID: 16274944
[TBL] [Abstract][Full Text] [Related]
13. Effects of formulation parameters on encapsulation efficiency and release behavior of thienorphine loaded PLGA microspheres.
Yang Y; Gao Y; Mei X
Pharm Dev Technol; 2013; 18(5):1169-74. PubMed ID: 21967467
[TBL] [Abstract][Full Text] [Related]
14. Development of PEG-PLA/PLGA microparticles for pulmonary drug delivery prepared by a novel emulsification technique assisted with amphiphilic block copolymers.
Takami T; Murakami Y
Colloids Surf B Biointerfaces; 2011 Oct; 87(2):433-8. PubMed ID: 21715147
[TBL] [Abstract][Full Text] [Related]
15. Versatility of biodegradable poly(D,L-lactic-co-glycolic acid) microspheres for plasmid DNA delivery.
Díez S; Tros de Ilarduya C
Eur J Pharm Biopharm; 2006 Jun; 63(2):188-97. PubMed ID: 16697172
[TBL] [Abstract][Full Text] [Related]
16. Bupivacaine-loaded biodegradable poly(lactic-co-glycolic) acid microspheres I. Optimization of the drug incorporation into the polymer matrix and modelling of drug release.
Zhang H; Lu Y; Zhang G; Gao S; Sun D; Zhong Y
Int J Pharm; 2008 Mar; 351(1-2):244-9. PubMed ID: 18024022
[TBL] [Abstract][Full Text] [Related]
17. Properties of poly(lactic-co-glycolic acid) nanospheres containing protease inhibitors: camostat mesilate and nafamostat mesilate.
Yin J; Noda Y; Yotsuyanagi T
Int J Pharm; 2006 May; 314(1):46-55. PubMed ID: 16551494
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of different buffers on plasmid DNA encapsulation into PLGA microparticles.
Tse MT; Blatchford C; Oya Alpar H
Int J Pharm; 2009 Mar; 370(1-2):33-40. PubMed ID: 19059325
[TBL] [Abstract][Full Text] [Related]
19. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.
Witschi C; Doelker E
J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930
[TBL] [Abstract][Full Text] [Related]
20. Water-free microencapsulation of proteins within PLGA microparticles by spray drying using PEG-assisted protein solubilization technique in organic solvent.
Mok H; Park TG
Eur J Pharm Biopharm; 2008 Sep; 70(1):137-44. PubMed ID: 18515053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
